Press Releases

Öffentliches Kaufangebot für alle sich im Publikum befindenden Namenaktien mit einem Nennwert von je CHF 0.10 von Syngenta AG, Schweiz

Offre publique d'acquisition sur toutes les actions nominatives d'une valeur nominale de CHF 0.10 chacune en mains du public de Syngenta SA, Suisse

Public tender offer for all publicly held registered shares with a nominal value of CHF 0.10 each of Syngenta Ltd, Switzerland

Angebotsrestriktionen | Restrictions à l'Offre | Offer Restrictions

Allgemein | Généralités | In General

Das in den auf dieser Website verfügbar gemachten Dokumenten beschriebene öffentliche Kaufangebot (das Schweizer Angebot) wurde weder direkt noch indirekt in einem Land oder einer Rechtsordnung unterbreitet, in welchem/welcher ein solches Schweizer Angebot widerrechtlich gewesen wäre, oder in welchem/welcher es in anderer Weise anwendbares Recht verletzt worden, oder in welchem/welcher China National Chemical Corporation (ChemChina) oder einer ihrer direkten oder indirekten Tochtergesellschaften verpflichtet gewesen wäre, irgendeine Änderung oder Anpassung der Bestimmungen oder Bedingungen des Schweizer Angebots, ein zusätzliches Gesuch an staatliche. regulatorische oder andere Behörden oder zusätzliche Handlungen in Bezug auf das Schweizer Angebot vorzunehmen. Es war nicht beabsichtigt, das Schweizer Angebot auf ein solches Land oder eine solche Rechtsordnung zu erstrecken. Dokumente, die im Zusammenhang mit dem Schweizer Angebot stehen, durften weder in solchen Ländern oder Rechtsordnungen vertrieben, noch in solche Länder oder Rechtsordnungen versandt werden und durften von niemandem zur Werbung für Käufe von Beteiligungsrechten an Syngenta AG, Schweiz, in solchen Ländern oder Rechtsordnungen verwendet werden.

L'Offre décrite dans les documents disponible sur ce site web (l'Offre suisse) n'a été faite ni directement ni indirectement dans aucun Etat ou une juridiction dans lequel|laquelle une telle Offre suisse aurait été illicite ou aurait enfreint de toute autre manière les lois ou réglementations en vigueur ou qui aurait exigé de la part de China National Chemical Corporation (ChemChina) ou l'une de ses filiales directes ou indirectes un changement ou une modification des termes ou des conditions de l'Offre suisse de quelque manière que ce soit, la formulation d'une demande en lien avec l'Offre suisse auprès d'une quelconque autorité gouvernementale, régulatrice ou autre, ou des démarches supplémentaires en lien avec l'Offre suisse. Il n'était pas prévu d'étendre l'Offre suisse à de tels Etats ou juridictions. Les documents relatifs à l'Offre suisse ne devaient être ni distribués ni envoyés dans de tels Etats ou juridictions. De tels documents ne devaient pas non plus être utilisés pour solliciter l'acquisition de titres de participation de Syngenta SA, Suisse, par toute personne ou entité domiciliée ou ayant son siège dans de tels Etats ou juridictions.

The public tender offer described in the documents available on this website (the Swiss Offer) was not made, directly or indirectly, in any country or jurisdiction in which such Swiss Offer would have been considered unlawful or otherwise violated any applicable laws or regulations, or which would have required China National Chemical Corporation (ChemChina) or any of its affiliates to change or amend the terms or conditions of the Swiss Offer in any way, to make an additional filing with any governmental, regulatory or other authority or take additional action in relation to the Swiss Offer. It was not intended to extend the Swiss Offer to any such country or jurisdiction. Documents relating to the Swiss Offer were neither to be distributed in any such country or jurisdiction nor to be sent into such country or jurisdiction. Any such documents were not to be used for the purpose of soliciting the purchase of any securities of Syngenta Ltd, Switzerland, by any person or entity resident or incorporated in any such country or jurisdiction.

Notice to U.S. Persons Holding Syngenta Shares and to Holders of ADSs

The Swiss Offer described in the documents available on this website was made for the registered shares of Syngenta Ltd, Switzerland (Syngenta), a Swiss company whose shares are listed on the SIX Swiss Exchange (SIX), and was subject to Swiss disclosure and procedural requirements, which are different from those of the United States (U.S.). The Swiss Offer was made in the U.S. pursuant to Section 14(d) and Section 14(e) of, and Regulation 14D and Regulation 14E under, the U.S. Securities Exchange Act of 1934, as amended (the U.S. Exchange Act), subject to the exemptions provided by Rule 14d-1(d) under the U.S. Exchange Act, and otherwise in accordance with the requirements of Swiss law. Accordingly, the Swiss Offer was subject to disclosure and other procedural requirements, including with respect to withdrawal rights (which may or may not have applied), settlement procedures and timing of payments that were different from those applicable under U.S. domestic tender offer procedures and laws.

In accordance with the laws of Switzerland and subject to applicable regulatory requirements, ChemChina and its subsidiaries or their nominees or brokers (acting as agents for ChemChina or any of its subsidiaries) may from time to time after the date hereof, and other than pursuant to the Swiss Offer, directly or indirectly purchase, or arrange to purchase, registered shares of Syngenta (Syngenta Shares) or any securities that are convertible into, exchangeable for or exercisable for Syngenta Shares. These purchases, or arrangements to purchase, may occur either in the open market at prevailing prices or in private transactions at negotiated prices and shall comply with applicable laws and regulations in Switzerland and applicable U.S. securities laws. Any such purchases will not be made at prices higher than the offer price or on terms more favorable than those offered pursuant to the Swiss Offer unless the offer price is increased accordingly. Any information about such purchases or arrangements to purchase will be publicly disclosed in the U.S. on www.chemchina.com/press to the extent that such information is made public in accordance with the applicable laws and regulations of Switzerland. In addition, the financial advisors to ChemChina, the Offeror and Syngenta may also engage in ordinary course trading activities in securities of Syngenta, which may include purchases or arrangements to purchase such securities.

It may be difficult for holders of Syngenta Shares who were U.S. holders within the meaning of Rule 14d-1(d) under the U.S. Exchange Act (U.S. Persons) to enforce their rights and any claim arising out of U.S. securities laws, since each of ChemChina, the Offeror and Syngenta is located in a non-U.S. jurisdiction, and some or all of their officers and directors may be residents of a non-U.S. jurisdiction. U.S. Persons may not be able to sue a non-U.S. company or its officers or directors in a U.S. or non-U.S. court for violations of the U.S. securities laws. Further, it may be difficult to compel a non-U.S. company and its affiliates to subject themselves to a U.S. court's judgment.

Neither the U.S. Securities and Exchange Commission (SEC) nor any securities commission of any State of the U.S. (a) approved or disapproved of the Swiss Offer; (b) passed upon the merits or fairness of the Swiss Offer; or (c) passed upon the adequacy or accuracy of the disclosure in the Swiss Offer documents. Any representation to the contrary is a criminal offence in the U.S.

ChemChina or a designated direct or indirect subsidiary thereof launched a public tender offer in the U.S. to all holders of American Depositary Shares of Syngenta (ADSs) issued by Bank of New York Mellon acting as depositary (the U.S. Depositary) and listed on the New York Stock Exchange and to holders of Syngenta Shares who are U.S. Persons pursuant to a separate U.S. offer documentation (the U.S. Offer) which was filed with the SEC, including the Schedule TO filed by ChemChina and CNAC Saturn (NL) B.V. and the Solicitation/Recommendation Statement on Schedule 14D-9 with respect to the U.S. Offer filed by Syngenta. A free copy of these documents , and other documents filed by Syngenta and the relevant offeror with the SEC, can be obtained at the SEC's website at www.sec.gov.

The Swiss Offer was not addressed to holders of ADSs.

United Kingdom

In the United Kingdom (U.K.), the communication about the Swiss Offer was directed only at persons (i) who had professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”), (ii) falling within article 49(2)(a) to (d) ("high net worth companies, unincorporated associations, etc.") of the Order or (iii) to whom it could otherwise lawfully be communicated (all such persons together being referred to as "relevant persons"). This communication could not be acted on or relied on by persons who were not relevant persons. Any investment or investment activity to which this communication related was available only to relevant persons and would be engaged in only with relevant persons.

Notice to Australian Residents

The Swiss Offer was made in compliance with the laws of Switzerland. The Swiss Offer was not regulated by the Australian Corporations Act 2001 (Cth), the Australian Takeovers Panel, the Australian Securities & Investments Commission or the rules of the Australian Securities Exchange (together, the Australian Regulations). The content of the offer document and the takeover procedures were regulated by the laws of Switzerland and not by the Australian Regulations.

Confirmation

By clicking on the "I confirm and agree" button below, you confirm and agree to each of the following:

—         that you have read and understood and that you are not subject to any of the Swiss Offer restrictions set forth above, that the communication about the Swiss Offer may lawfully be directed at and the Swiss Offer lawfully addressed to you;

—         that you are not located or resident in any jurisdiction where extension of the Swiss Offer would trigger a requirement for ChemChina or any of its affiliates or any other person to file or register an offer prospectus or any other document, or to take any other or additional action in relation to the Swiss Offer, in or by virtue of the laws of such jurisdiction;

—         that you will not copy or forward to any person any of the documents available on this website; and

—         that you understand, acknowledge and agree that failure to comply with the foregoing could result in a violation of applicable laws and|or damages to ChemChina, its affiliates and other persons.

Contact Us | Site Map | Legal | Feedback | Links | RSS | FAQs
.All rights reserved. Without written authorization from ChemChina, such content shall not be republished
or used in any form.
Produced By CMS 网站群内容管理系统 publishdate:2017/12/11 09:58:12